Atlas Trials

Study to Assess the Efficacy and Safety of Raxone in LHON Patients

Clinical trial NCT02774005 · COMPLETED

Trial details

NCT number
NCT02774005
Sponsor
Santhera Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Leber's Hereditary Optic Neuropathy (LHON)
Start date
2016-05-01
Primary completion
2021-03-29
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.